A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer

Validated biomarker signatures that predict pathologic response to preoperative chemoradiation therapy (CTRT) with high specificity and desirable sensitivity levels in patients with esophageal cancer (EC).

(2017) J. A. Ajani et al.   JOURNAL OF CLINICAL ONCOLOGY

Esophageal and Esophagogastric Junction Cancers

(2017) Jaffer A. Ajani et al.   Journal of the National Comprehensive Cancer Network

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

(2013) Robert Haddad et al.   LANCET ONCOLOGY

Cancer Genome Landscapes

(2013) B. Vogelstein et al.   SCIENCE

Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer

(2012) J. A. Ajani et al.   ANNALS OF ONCOLOGY

Clinical relevance of induction triplet chemotherapy for esophageal cancer invading adjacent organs

(2012) Hiroshi Miyata et al.   JOURNAL OF SURGICAL ONCOLOGY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?

(2011) Jae Y. Kim et al.   ANNALS OF THORACIC SURGERY

Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

(2009) William H. Allum et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction

(2009) Michael Stahl et al.   JOURNAL OF CLINICAL ONCOLOGY